Find the partnership program with SOM Biotech that’s right for you
Pipeline expansion within any therapeutic area.
Life cycle management of existing products to expand opportunities on the market.
New targets identification for your shelved assets.
Indication expantion for your assets in development.
In-licensing of our advanced assets.
Co-development or in-licensing of our early-stage assets.
We use a unique approach based on our Artificial Intelligence based technology SOMAI PRO and the expertise of our Team and Key Opinion Leaders.
Learn about our Approach
Our pipeline
3 products reached Clinical Phase 2
2 products in Preclinical Development
20 products in Early-stage Pipeline
Learn about our Pipeline
OUR SUCCESSFULL DEALS
We have
2 licensing out deals
Read our news
